4//SEC Filing
TRANSKARYOTIC THERAPIES INC 4
Accession 0001104659-05-035139
CIK 0000885259operating
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 4:44 PM ET
Size
5.9 KB
Accession
0001104659-05-035139
Insider Transaction Report
Form 4
Pauwels Eric
Sr. VP- Global Commercial Ops
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2005-07-27$9.26/sh−100,000$926,000→ 0 totalExercise: $27.74Exp: 2015-04-13→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option, which was granted on April 13, 2005 and provided for vesting in five equal annual installments beginning on April 13, 2006, was cancelled pursuant to a merger agreement among the Issuer, Shire Pharmaceuticals Group plc and Sparta Acquisition Corporation, dated April 21, 2005, in exchange for a cash payment of $926,000, representing the excess of $37.00 over the per share exercise price of the option multiplied by the number of shares subject to the option, whether vested or unvested.
Documents
Issuer
TRANSKARYOTIC THERAPIES INC
CIK 0000885259
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000885259
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 4:44 PM ET
- Size
- 5.9 KB